XAIR News and Press, Beyond Air Inc. From 06/16/23

2023-06-16 14:00:09 ET A holiday-shortened week leaves the list of earnings announcements rather thin. Still, a handful of high-profile names makes for a potent schedule of quarterly results. FedEx ( NYSE: FDX ) will headline the penultimate week of June with a hotly anticipated...

GARDEN CITY, N.Y., June 15, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with resp...

Hebrew University’s preclinical results recently published in Advanced Science show a reversal of the molecular, synaptic and behavioral autism spectrum disorder (ASD) phenotypes Plan to initiate a first-in-human clinical trial of nNOS for treatment of ASD in 2025 Conferenc...

2023-06-15 13:01:50 ET Shares of Beyond Air ( NASDAQ: XAIR ) added ~6% on Thursday on above-average volume to approach the highest level since mid-April after BTIG launched its coverage with a Buy recommendation citing a “catalyst-rich pipeline.” 348.0K Beyond ...

2023-06-15 08:21:52 ET Leju Holdings  ( LEJU ) +40% . CBAK Energy Technology ( CBAT ) +26% Received Order From Viessmann Group for EUR116.5 Million of Lithium-Ion Batteries for 2024. BitNile Metaverse ( BNMV ) +24% . Applied UV ( AUVI ) +20% ...

GARDEN CITY, N.Y., May 16, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pul...

Single and repeat dosing of UNO improves outcomes compared to checkpoint inhibitor monotherapy in the aggressive 4T1 breast cancer model mPD-L1 upregulation following UNO treatment helps to elucidate the mechanism for the previously reported sensitization of tumors to immune checkpoint ...

GARDEN CITY, N.Y., March 23, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with res...

2023-03-10 08:58:00 ET Medical device maker Beyond Air ( NASDAQ: XAIR ) added ~4% in the pre-market trading following a series of insider purchases from its top management, including the chief executive officer and chief operating officer. According to regulatory f...

GARDEN CITY, N.Y., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”) a commercial stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respi...